Cargando…
Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases
Normal pregnancy is a state of hypercoagulability with diminishing fibrinolytic activity, which is mainly caused by an increase of plasminogen activator inhibitor type 1 (PAI-1). PAI-1 is the main inhibitor of plasminogen activators, including tissue-type plasminogen activator (tPA) and urokinase-ty...
Autores principales: | Ye, Yao, Vattai, Aurelia, Zhang, Xi, Zhu, Junyan, Thaler, Christian J., Mahner, Sven, Jeschke, Udo, von Schönfeldt, Viktoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578041/ https://www.ncbi.nlm.nih.gov/pubmed/28758928 http://dx.doi.org/10.3390/ijms18081651 |
Ejemplares similares
-
Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)
por: Ye, Yao, et al.
Publicado: (2020) -
Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI
por: Rogenhofer, Nina, et al.
Publicado: (2022) -
Prostaglandin E(2) receptor 3 signaling is induced in placentas with unexplained recurrent pregnancy losses
por: Ye, Yao, et al.
Publicado: (2018) -
Early Life Oxidative Stress and Long-Lasting Cardiovascular Effects on Offspring Conceived by Assisted Reproductive Technologies: A Review
por: Yang, Huixia, et al.
Publicado: (2020) -
Role of Placental VDR Expression and Function in Common Late Pregnancy Disorders
por: Knabl, Julia, et al.
Publicado: (2017)